1. Home
  2. ISSC vs GLSI Comparison

ISSC vs GLSI Comparison

Compare ISSC & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Solutions and Support Inc.

ISSC

Innovative Solutions and Support Inc.

HOLD

Current Price

$20.26

Market Cap

380.6M

Sector

Technology

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$23.65

Market Cap

372.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISSC
GLSI
Founded
1988
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.6M
372.0M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
ISSC
GLSI
Price
$20.26
$23.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$16.50
$50.00
AVG Volume (30 Days)
772.5K
137.5K
Earning Date
05-13-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
N/A
EPS
0.22
N/A
Revenue
N/A
N/A
Revenue This Year
$6.63
N/A
Revenue Next Year
$8.13
N/A
P/E Ratio
$88.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.30
$7.78
52 Week High
$30.98
$34.10

Technical Indicators

Market Signals
Indicator
ISSC
GLSI
Relative Strength Index (RSI) 35.55 45.72
Support Level $17.57 $21.43
Resistance Level $22.60 $30.02
Average True Range (ATR) 2.13 2.21
MACD -1.37 -0.45
Stochastic Oscillator 9.82 33.44

Price Performance

Historical Comparison
ISSC
GLSI

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: